Aaron Mendelsohn

Mr. Mendelsohn is a founder and has been a director of Second Sight since the company’s inception. Mr. Mendelsohn joined the board of Advanced Bionics shortly after its founding in 1993 and served on the board until the company’s sale in 2004. Mr. Mendelsohn was also a founder and director of MRG from its inception in 1998 until its sale in 2001 to Medtronic, Inc. Mr. Mendelsohn has served on the board of directors for the Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California since its inception in 1998 and is a member of its Executive Committee. In 2007, Mr. Mendelsohn founded Nanoprecision Holding Company, Inc., a world leader in manipulating materials at the nanometer scale, and has served on its board of directors since then. He is also a founder and director of Nanoprecision Medical, Inc., a drug delivery company working in nanotechnology, since its inception in 2011. Mr. Mendelsohn serves as Chairman of the Maestro Foundation, a leading non-profit musical philanthropic organization that hosts a premier chamber music series and lends professional-level instruments and bows to young, career-bound classical musicians, which he founded in 1983. Mr. Mendelsohn received his B.A. from UCLA and J.D. from Loyola University School of Law Los Angeles. Our board believes that Mr. Mendelsohn’s business experience, including his experience as a founder, board member, and executive officer of medical device companies, combined with his financial experience, business acumen, and judgment provide our Board with valuable managerial and operational expertise and leadership skills making him well qualified to serve as one of our directors.